🇺🇸 FDA
Patent

US 12220424

Compositions comprising nicotinamide riboside and a urolithin

granted A61KA61K2300/00A61K31/366

Quick answer

US patent 12220424 (Compositions comprising nicotinamide riboside and a urolithin) held by Amazentis SA expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amazentis SA
Grant date
Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2300/00, A61K31/366, A61K31/706, A61K9/0053